Breast Reduction
9
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Parasternal Block Added to Serratus Anterior Plane Block in Breast Reduction Surgery
CO2Lift and T-Junction Breakdown Rates Evaluation After Breast Reduction Surgery Pilot Trial
Surgeon-Guided Serratus Block in Breast Reduction Surgery
A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction
The Impact of Nutritional Optimization to Enhance Postoperative Outcomes Using the R-Support Supplements
Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery
Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use
Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery